We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBRA icon
101
Sabra Healthcare REIT
SBRA
$5.18B
$11.7M 0.33%
+504,000
New +$11.4M
ZEN
102
DELISTED
ZENDESK INC
ZEN
$11.6M 0.33%
163,600
-8,500
-5% -$543K
C icon
103
Citigroup
C
$228B
$11.3M 0.33%
158,010
– –
THO icon
104
Thor Industries
THO
$3.71B
$11.2M 0.32%
133,411
-2,740
-2% -$262K
SSD icon
105
Simpson Manufacturing
SSD
$7.09B
$11.2M 0.32%
+154,101
New +$10.9M
DIN icon
106
Dine Brands
DIN
$343M
$11.1M 0.32%
137,005
-21,975
-14% -$1.7M
PCRX icon
107
Pacira BioSciences
PCRX
$960M
$11.1M 0.32%
+225,545
New +$9.75M
GHDX
108
DELISTED
Genomic Health, Inc.
GHDX
$10.9M 0.31%
155,535
+29,150
+23% +$1.71M
PCTY icon
109
Paylocity
PCTY
$7.81B
$10.9M 0.31%
+135,465
New +$9.6M
ADSW
110
DELISTED
Advanced Disposal Services Inc
ADSW
$10.8M 0.31%
397,630
+109,960
+38% +$2.82M
HXL icon
111
Hexcel
HXL
$6.91B
$10.8M 0.31%
160,545
-6,635
-4% -$450K
LNG icon
112
Cheniere Energy
LNG
$56B
$10.7M 0.31%
154,040
– –
WAL icon
113
Western Alliance Bancorporation
WAL
$8.62B
$10.7M 0.31%
187,199
-90,585
-33% -$5.22M
FANG icon
114
Diamondback Energy
FANG
$59.2B
$10.5M 0.3%
77,727
-670
-0.9% -$85.5K
CUB
115
DELISTED
Cubic Corporation
CUB
$10.4M 0.3%
141,775
-2,230
-2% -$160K
PAA icon
116
Plains All American Pipeline
PAA
$18.2B
$9.86M 0.28%
394,240
+43,450
+12% +$1.09M
ICUI icon
117
ICU Medical
ICUI
$3.9B
$9.81M 0.28%
34,695
-34,645
-50% -$10.1M
NDLS icon
118
Noodles & Co
NDLS
$81.2M
$9.66M 0.28%
+99,794
New +$9.24M
NOVT icon
119
Novanta
NOVT
$5.23B
$9.66M 0.28%
141,169
-2,190
-2% -$154K
WCG
120
DELISTED
Wellcare Health Plans, Inc.
WCG
$9.65M 0.28%
30,115
-2,565
-8% -$728K
NVEE
121
DELISTED
NV5 Global
NVEE
$9.63M 0.28%
+444,420
New +$9.16M
AAN.A
122
DELISTED
The Aaron's Company Inc Class A
AAN.A
$9.63M 0.28%
176,835
-7,280
-4% -$396K
ROKU icon
123
Roku
ROKU
$23.3B
$9.62M 0.28%
+131,745
New +$7.55M
PNC icon
124
PNC Financial Services
PNC
$96.1B
$9.62M 0.28%
70,600
– –
ADUS icon
125
Addus HomeCare
ADUS
$2.16B
$9.6M 0.28%
+136,775
New +$8.86M
3 4
5
6 7

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.